Cumberland Pharmaceuticals Inc. Operating Leases, Rent Expense, Sublease Rentals
Cumberland Pharmaceuticals Inc. (CPIX) reported Operating Leases, Rent Expense, Sublease Rentals of $348.41 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2021-08-13
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for the quarter ending 2021-06-30 was $170.38K, a 10.74% increase year-over-year.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for the quarter ending 2021-03-31 was $178.03K, a 4.95% increase year-over-year.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for the quarter ending 2020-06-30 was $153.86K.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for the quarter ending 2020-03-31 was $169.63K.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for fiscal 2020 was $680.63K, a 1.07% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for fiscal 2019 was $688.02K, a 3.87% increase from fiscal 2018.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for fiscal 2018 was $662.36K.
- Cumberland Pharmaceuticals Inc. operating leases, rent expense, sublease rentals for fiscal 2016 was $646.24K, a 17.40% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 12 month | Operating Leases, Rent Expense, Sublease Rentals 12 month as first filed |
|---|---|---|---|---|
| 2021-06-30 | $170.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $348.41K 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | $178.03K 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | $680.63K 10-K · filed 2021-03-12 | |||
| 2020-06-30 | $153.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $323.49K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $169.63K 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $688.02K 10-K · filed 2021-03-12 | |||
| 2018-12-31 | $662.36K 10-K · filed 2021-03-12 | |||
| 2017-12-31 | $573.49K 8-K · filed 2020-12-10 | |||
| 2016-12-31 | $646.24K 10-K · filed 2019-03-12 | $600.00K 10-K · filed 2017-03-13 | ||
| 2015-12-31 | $550.45K 10-K · filed 2018-03-09 | $600.00K 10-K · filed 2016-03-14 | ||
| 2014-12-31 | $500.00K 10-K · filed 2017-03-13 | |||
| 2013-12-31 | $500.00K 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $500.00K 10-K · filed 2015-03-09 | |||
| 2011-12-31 | $400.00K 10-K · filed 2014-03-11 | |||
| 2010-12-31 | $300.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |